» Articles » PMID: 21880927

Overexpression of Neurotrophin-3 Stimulates a Second Wave of Dopaminergic Amacrine Cell Genesis After Birth in the Mouse Retina

Overview
Journal J Neurosci
Specialty Neurology
Date 2011 Sep 2
PMID 21880927
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Dopaminergic amacrine (DA) cells play multiple and important roles in retinal function. Neurotrophins are known to modulate the number and morphology of DA cells, but the underlying regulatory mechanisms are unclear. Here, we investigate how neurotrophin-3 (NT-3) regulates DA cell density in the mouse retina. We demonstrate that overexpression of NT-3 upregulates DA cell number and leads to a consequent increase in the density of DA cell dendrites. To examine the mechanisms of DA cell density increase, we further investigate the effect of NT-3 overexpression on retinal apoptosis and mitosis during development. We find that NT-3 does not affect the well known wave of retinal cell apoptosis that normally occurs during the first 2 weeks after birth. Instead, overexpression of NT-3 promotes additional mitosis of DA cells at postnatal day 4, but does not affect cell mitosis before birth, the peak period of amacrine cell genesis in wild-type retinas. We next show that retinal explants cultured from birth to day 7 without extra NT-3 produced by lens exhibit similar number of DA cells as in wild type, further supporting the notion that postnatal overexpression of lens-derived NT-3 affects DA cell number. Moreover, the additional mitosis after birth in NT-3-overexpressing mice does not occur in calretinin-positive amacrine cells or PKC-positive rod ON bipolar cells. Thus, the NT-3-triggered wave of cell mitosis after birth is specific for the retinal DA cells.

Citing Articles

Light activation of the dopaminergic system occurs after eye-opening in the mouse retina.

Jain V, Liang P, Raja S, Mikhael M, Cameron M Front Ophthalmol (Lausanne). 2024; 3:1184627.

PMID: 38983102 PMC: 11182289. DOI: 10.3389/fopht.2023.1184627.


Results from the Population-Based Gutenberg Health Study Revealing Four Altered Autoantibodies in Retinal Vein Occlusion Patients.

Bell K, Beutgen V, Nickels S, Lorenz K, Scheller Y, Elbaz H J Ophthalmol. 2020; 2020:8386160.

PMID: 32802490 PMC: 7411451. DOI: 10.1155/2020/8386160.


Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells.

Edwards G, Perkins G, Kim K, Kong Y, Lee Y, Choi S Cell Death Dis. 2020; 11(4):254.

PMID: 32312949 PMC: 7170863. DOI: 10.1038/s41419-020-2456-6.


Dopaminergic amacrine cell number, plexus density, and dopamine content in the mouse retina: Strain differences and effects of Bax gene disruption.

Sankaran M, Keeley P, He L, Iuvone P, Reese B Exp Eye Res. 2018; 177:208-212.

PMID: 30240584 PMC: 6261691. DOI: 10.1016/j.exer.2018.09.008.


Overexpression of Brain-Derived Neurotrophic Factor Protects Large Retinal Ganglion Cells After Optic Nerve Crush in Mice.

Feng L, Puyang Z, Chen H, Liang P, Troy J, Liu X eNeuro. 2017; 4(1).

PMID: 28101532 PMC: 5240030. DOI: 10.1523/ENEURO.0331-16.2016.


References
1.
Feng L, Xie X, Joshi P, Yang Z, Shibasaki K, Chow R . Requirement for Bhlhb5 in the specification of amacrine and cone bipolar subtypes in mouse retina. Development. 2006; 133(24):4815-25. PMC: 2992969. DOI: 10.1242/dev.02664. View

2.
Hatakeyama J, Kageyama R . Retrovirus-mediated gene transfer to retinal explants. Methods. 2003; 28(4):387-95. DOI: 10.1016/s1046-2023(02)00257-8. View

3.
Nag T, Wadhwa S . Neurotrophin receptors (Trk A, Trk B, and Trk C) in the developing and adult human retina. Brain Res Dev Brain Res. 1999; 117(2):179-89. DOI: 10.1016/s0165-3806(99)00121-2. View

4.
Hackam A . Regulation of neurotrophin expression and activity in the retina. Adv Exp Med Biol. 2008; 613:343-9. DOI: 10.1007/978-0-387-74904-4_40. View

5.
Raven M, Eglen S, Ohab J, Reese B . Determinants of the exclusion zone in dopaminergic amacrine cell mosaics. J Comp Neurol. 2003; 461(1):123-36. DOI: 10.1002/cne.10693. View